Rifampicin Combination Therapy Versus Monotherapy for Staphylococcal Prosthetic Joint Infection
Status:
Recruiting
Trial end date:
2028-03-01
Target enrollment:
Participant gender:
Summary
In this Dutch multicenter clinical trial, patients with a staphylococcal prosthetic joint
infection, will, in the oral antibiotic treatment phase, be randomized between clindamycin
monotherapy and rifampicin / levofloxacin combination therapy. The clinical endpoint will be
treatment success one year after finishing antimicrobial treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Leiden University Medical Center
Collaborators:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Alrijne Hospital Elisabeth-TweeSteden Ziekenhuis Erasmus Medical Center Isala Martini Hospital Groningen Medical Centre Leeuwarden Onze Lieve Vrouwe Gasthuis Radboud University Medical Center Reinier Haga Orthopedisch Centrum Rijnstate Hospital Sint Maartenskliniek Spaarne Gasthuis Tergooi Hospital University Medical Center Groningen